AR035679A1 - Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los - Google Patents

Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los

Info

Publication number
AR035679A1
AR035679A1 ARP020100030A ARP020100030A AR035679A1 AR 035679 A1 AR035679 A1 AR 035679A1 AR P020100030 A ARP020100030 A AR P020100030A AR P020100030 A ARP020100030 A AR P020100030A AR 035679 A1 AR035679 A1 AR 035679A1
Authority
AR
Argentina
Prior art keywords
sales
pharmaceutically acceptable
compounds
acid
difluorpirrolidinil
Prior art date
Application number
ARP020100030A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR035679A1 publication Critical patent/AR035679A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ARP020100030A 2001-01-05 2002-01-04 Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los AR035679A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05

Publications (1)

Publication Number Publication Date
AR035679A1 true AR035679A1 (es) 2004-06-23

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100030A AR035679A1 (es) 2001-01-05 2002-01-04 Sales farmaceuticamente aceptables del acido 3s,4ar,8ar-6-(((2s)-2-(carboxil)-4,4,-difluorpirrolidinil)metil)-1,2,3,4,4a,5,6,7,8,8a-decahidroisoquinolin-3-carboxilico, prodrogas de dichos compuestos; metodo para tratar desordenes neurologicos o neurodegenerativos utilizando dichas sales; uso de los

Country Status (23)

Country Link
EP (1) EP1351955A1 (hr)
JP (1) JP2004520335A (hr)
KR (1) KR20030066797A (hr)
CN (1) CN1484642A (hr)
AR (1) AR035679A1 (hr)
BR (1) BR0116672A (hr)
CA (1) CA2431545A1 (hr)
CZ (1) CZ20031856A3 (hr)
DZ (1) DZ3460A1 (hr)
EA (1) EA200300770A1 (hr)
EC (1) ECSP034682A (hr)
HR (1) HRP20030544A2 (hr)
HU (1) HUP0302528A2 (hr)
IL (1) IL156138A0 (hr)
MX (1) MXPA03005981A (hr)
NO (1) NO20032973D0 (hr)
NZ (1) NZ525821A (hr)
PE (1) PE20020792A1 (hr)
PL (1) PL361934A1 (hr)
SK (1) SK8242003A3 (hr)
TW (1) TW591023B (hr)
WO (1) WO2002053561A1 (hr)
ZA (1) ZA200304311B (hr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
KR20010040711A (ko) * 1998-02-06 2001-05-15 피터 기딩스 파록세틴의 염
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
EP1200073B1 (en) * 1999-07-06 2007-01-10 Eli Lilly And Company SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE

Also Published As

Publication number Publication date
KR20030066797A (ko) 2003-08-09
PL361934A1 (en) 2004-10-18
SK8242003A3 (en) 2004-01-08
CZ20031856A3 (cs) 2003-09-17
CA2431545A1 (en) 2002-07-11
MXPA03005981A (es) 2003-09-10
IL156138A0 (en) 2003-12-23
JP2004520335A (ja) 2004-07-08
HRP20030544A2 (en) 2004-08-31
ZA200304311B (en) 2004-09-02
PE20020792A1 (es) 2002-09-06
HUP0302528A2 (hu) 2003-11-28
NO20032973L (no) 2003-06-27
ECSP034682A (es) 2003-08-29
BR0116672A (pt) 2003-09-23
TW591023B (en) 2004-06-11
NO20032973D0 (no) 2003-06-27
NZ525821A (en) 2004-07-30
EA200300770A1 (ru) 2003-10-30
DZ3460A1 (fr) 2002-07-11
WO2002053561A1 (en) 2002-07-11
EP1351955A1 (en) 2003-10-15
CN1484642A (zh) 2004-03-24

Similar Documents

Publication Publication Date Title
ECSP034712A (es) Ciclobuteno-1.2-dionas 3,4-di-substituidas como antagonistas del receptor quimiocina cxc
ECSP034640A (es) Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato
CR8349A (es) Derivados de dihidrobenzofuranilo alcanamina y metodos para su uso
AR047992A1 (es) Diaminopirimidinas como antagonistas de p2x3 y p2x2/3
PA8591701A1 (es) Derivados de pirrolopirimidina
CY1111977T1 (el) Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
UY29710A1 (es) Benzimidazoles tricíclicos y su uso como moduladores de receptores metabotrópicos de glutamato
PE20010205A1 (es) Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato
EA200600190A1 (ru) Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона
GT199800021A (es) Utilizacion de antagonistas de los receptores de canabinoides centrales para la preparacion de medicamentos.
EA201170473A1 (ru) Морфинановые соединения
BR0104834A (pt) Moduladores de receptores de glucocorticóides
AR028824A1 (es) Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos.
AR040278A1 (es) Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos
ECSP056192A (es) 3-fluoro-piperidinas como antagonistas de nmda/nr2b
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
DE60120077D1 (de) Modulatoren des Glucocorticoid-Rezeptors
CL2004000769A1 (es) Compuestos derivados del acido [2-(8,9-dioxo-2,6-diazabiciclo [5,2,o]non-1-(7)-en-2-il) alquil]fosfonico, antagonistas del receptor n-metil-d-aspartato (nmda); procedimiento de preparacion; composicion farmaceutica; y su uso para tratar desordenes va
PE20050141A1 (es) DERIVADOS DE 2-ALQUINIL-Y 2-ALQUENIL-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIDINA COMO ANTAGONISTAS DEL RECEPTOR A2a ADENOSINA
AR066701A1 (es) 3-( imidazolil)- pirazolo {3,4-b] piridinas, composicion farmaceutica, proceso y uso en terapia
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
AR029373A1 (es) Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas
BRPI0417520A (pt) 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon
UY26919A1 (es) Derivados de la quinazolina como antagonistas adrenérgicos alfa - 1
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FA Abandonment or withdrawal